Monocyte/HDL ratio in sarcoidosis patients without treatment

dc.authorid
dc.contributor.authorGülhan, Pınar Yıldız
dc.contributor.authorElverişli, Mehmet Fatih
dc.date.accessioned2021-12-01T18:23:28Z
dc.date.available2021-12-01T18:23:28Z
dc.date.issued2020
dc.department[Belirlenecek]en_US
dc.description.abstractAim: This study examined the effects of monocyte/high-density lipoprotein cholesterol (HDL-C) ratio (MHR) and other inflammatorymarkers in patients with sarcoidosis not receiving treatment. To our knowledge, this is the first study on the relationship betweensarcoidosis and MHR.Material and Methods: This study included 53 patients with sarcoidosis who were followed at a single, outpatient tertiary-carecentre. Data on patient demographics (age and gender), disease characteristics (duration of disease, radiographic stage, treatments);pulmonary function tests (% predicted values for forced vital capacity [FVC], forced expiratory volume at 1 second [FEV1], diffusingcapacity of the lungs for carbon monoxide [DLCO], alveolar volume [VA], forced expiratory flow [25–75% and at 50%; FEF] [FEF25-75]),blood biochemistry and hemogram findings were retrieved from hospital records.Results: Mean ± SD patient age was 51.13 ±1 1.94 years. Of the 53 patients, 42 were female and 11 were male. When compared withMHR ratio and pulmonary function test parameters, there was a negative correlation with FEV1% (P = 0.043, r = ?0.279) and DLCO% (P= 0.009, r = –0.360). There was no significant correlation between FVC, FEV25-75 or VA. No significant correlation was found betweenblood calcium, urinary calcium, SACE (serum angiotensin converting enzyme) values and MHO ratio.Conclusions: Large-scale prospective studies are needed to determine if the use of MHR as an indicator of inflammation andactivation would be helpful in the diagnosis and monitoring of patients with sarcoidosis.en_US
dc.identifier.doi10.5455/annalsmedres.2020.01.063
dc.identifier.endpage1732en_US
dc.identifier.issn2636-7688
dc.identifier.issn2636-7688
dc.identifier.issue6en_US
dc.identifier.startpage1728en_US
dc.identifier.urihttps://doi.org/10.5455/annalsmedres.2020.01.063
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TXpneU9EWTBOQT09
dc.identifier.urihttps://hdl.handle.net/20.500.12684/9711
dc.identifier.volume27en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofAnnals of Medical Researchen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleMonocyte/HDL ratio in sarcoidosis patients without treatmenten_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
9711.pdf
Boyut:
161.38 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text